QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 8, 2006, 26(10):2767-2776; doi:10.1523/JNEUROSCI.5054-05.2006

This Article Full Text Full Text (PDF) Supplemental data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Cunningham, M. O. Articles by Racca, C. Search for Related Content PubMed PubMed Citation Articles by Cunningham, M. O. Articles by Racca, C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB KETAMINE HYDROCHLORIDE Medline Plus Health Information Mental Health

 Previous Article  |  Next Article 

Neurobiology of Disease
Region-Specific Reduction in Entorhinal Gamma Oscillations and Parvalbumin-Immunoreactive Neurons in Animal Models of Psychiatric Illness

Mark O. Cunningham,¹ Jillian Hunt,¹ Steven Middleton,² Fiona E. N. LeBeau,¹ Martin G. Gillies,¹ Ceri H. Davies,³ Peter R. Maycox,³ Miles A. Whittington,¹ and Claudia Racca¹

¹School of Neurology, Neurobiology, and Psychiatry, University of Newcastle, Newcastle NE2 4HH, United Kingdom, ²Faculty of Biological Sciences, University of Leeds, Leeds LS2 9NQ, United Kingdom, and ³Psychiatry Center of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, Essex, CM19 5AW, United Kingdom

Correspondence should be addressed to Claudia Racca, School of Neurology, Neurobiology, and Psychiatry, The Medical School, University of Newcastle-upon-Tyne, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK. Email: claudia.racca{at}ncl.ac.uk

Psychiatric illnesses, particularly schizophrenia, are associated with disrupted markers for interneuronal function and interneuron-mediated brain rhythms such as gamma frequency oscillations. Here we investigate a possible link between these two observations in the entorhinal cortex and hippocampus by using a genetic and an acute model of psychiatric illness. Lysophosphatidic acid 1 receptor-deficient (LPA1-deficient) mice show psychomotor-gating deficits and neurochemical changes resembling those seen in postmortem schizophrenia studies. Similar deficits are seen acutely with antagonism of the NMDA subtype of glutamate receptor. Neither model induced any change in power or frequency of gamma rhythms generated by kainate in hippocampal slices. In contrast, a dramatic decrease in the power of gamma oscillations was seen in superficial, but not deep, medial entorhinal cortex layers in both models. Immunolabeling for GABA, parvalbumin, and calretinin in medial entorhinal cortex from LPA1-deficient mice showed an 40% reduction in total GABA- and parvalbumin-containing neurons, but no change in the number of calretinin-positive neurons. This deficit was specific for layer II (LII). No change in the number of neurons positive for these markers was seen in the hippocampus. Acute NMDA receptor blockade, which selectively reduces synaptic drive to LII entorhinal interneurons, also disrupted gamma rhythms in a similar manner in superficial entorhinal cortex, but not in hippocampus. These data demonstrate an area-specific deficit in gamma rhythmogenesis in animal models of psychiatric illness and suggest that loss, or reduction in function, of interneurons having a large NMDA receptor expression may underlie the network dysfunction that is seen.

Key words: schizophrenia; LPA1 receptor; inhibition; entorhinal cortex; gamma oscillation; ketamine

---

Received Aug. 15, 2005; revised Jan. 18, 2006; accepted Jan. 22, 2006.

Correspondence should be addressed to Claudia Racca, School of Neurology, Neurobiology, and Psychiatry, The Medical School, University of Newcastle-upon-Tyne, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK. Email: claudia.racca{at}ncl.ac.uk

This article has been cited by other articles:

				A. K. Roopun, M. O. Cunningham, C. Racca, K. Alter, R. D. Traub, and M. A. Whittington Region-Specific Changes in Gamma and Beta2 Rhythms in NMDA Receptor Dysfunction Models of Schizophrenia Schizophr Bull, September 1, 2008; 34(5): 962 - 973. [Abstract] [Full Text] [PDF]

				G. Gonzalez-Burgos and D. A. Lewis GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia Schizophr Bull, September 1, 2008; 34(5): 944 - 961. [Abstract] [Full Text] [PDF]

				D. L. Jones and S. C. Baraban Characterization of Inhibitory Circuits in the Malformed Hippocampus of Lis1 Mutant Mice J Neurophysiol, November 1, 2007; 98(5): 2737 - 2746. [Abstract] [Full Text] [PDF]

				T. Hikida, H. Jaaro-Peled, S. Seshadri, K. Oishi, C. Hookway, S. Kong, D. Wu, R. Xue, M. Andrade, S. Tankou, et al. From the Cover: Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans PNAS, September 4, 2007; 104(36): 14501 - 14506. [Abstract] [Full Text] [PDF]

				A. K. Roopun, S. J. Middleton, M. O. Cunningham, F. E. N. LeBeau, A. Bibbig, M. A. Whittington, and R. D. Traub A beta2-frequency (20-30 Hz) oscillation in nonsynaptic networks of somatosensory cortex PNAS, October 17, 2006; 103(42): 15646 - 15650. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help